Rating History for Epizyme (EPZM) by Wedbush

More Stocks Rated by Wedbush | Latest Ratings for EPZM
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/27/2022 David Nierengarten Downgrade Neutral
(Outperform)		 N/A
(N/A)		 0.95
(1.47)		 54.74% Details